SYNTHESIS AND OXIDATION OF N-ALKYLACRIDANS

本文用金属钠和正戊醇还原N-烃基啶酮法合成了十一个N-烃基啶满,并用紫外光谱法研究了它们和DDQ、TCNE与CA的氧化反应。它们只能和DDQ形成电荷转移络合物,不能和TCNE或CA形成电荷转移络合物,其原因是DDQ有较强的络合能力和较弱的氧化能力,TCNE和CA则相反,有较弱的络合能力和较强的氧化能力。并用两种方法求得了N-烃基啶满的电离势(I_p)值,结果很接近。     

氯化聚乙烯弹性体的固相法合成

讨论了以固相法合成氯化聚乙烯（ＣＰＥ）弹性体的过程．实验结果表明，以固相氯化反应所得的ＣＰＥ，其大分子链上Ｃｌ取代基的分布比水相悬浮法更均匀．氯化过程的温度直接影响氯化速度及分子结构，如残留结晶、氯分布等．而聚乙烯颗粒表面与内部的氯化程度取决于氯化速度．大分子链上Ｃｌ取代基对邻近基团的氯化起阻碍作用     

四(三苯基膦)化钯催化的若干菲啶类化合物的合成

邻甲酰基芳基硼酸与取代邻溴苯胺经四(三苯基膦)化钯催化偶联缩合, 合成了9个菲啶衍生物。邻溴苯胺的取代基无论是吸电子或供电子基团, 反应均可顺利进行。     

对位取代酚钾与10′10′-二烃基-9,9′-联二吖啶盐电荷转移光谱的研究

10,10′-二烃基-9, 9′-联二吖啶盐有很强的荧光, 在光学材料^[1]和重金属离子的分析^[2]中有重要的应用价值。     

几种方酸菁染料的NMR及光谱特性研究

研究了几种方酸菁染料的核磁、可见、荧光光谱。通过二维核磁共振谱和¹³CNMR确定了分子的结构和构型。测定了其在不同溶剂中吸收光谱和荧光发射光谱及其发射的荧光量子产率。发现它具有微弱的正向溶致变色特性,通过光谱特征分析得出整个分子处于平面结构并形成一个长的共轭体系,其激发态和基态的结构相近的结论。同时,讨论了结构对分子电荷分布及相应荧光光谱特征的影响。     

Design,Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

The development of cancer treatments requires continuous exploration and improvement, in which the discovery of new drugs for the treatment of cancer is still an important pathway. In this study, based on the molecular hybridization strategy, a new structural framework with an N-aryl-N’-arylmethylurea scaffold was designed, and 16 new target compounds were synthesized and evaluated for their antiproliferative activities against four different cancer cell lines A549, MCF7, HCT116, PC3, and human liver normal cell line HL7702. The results have shown seven compounds with 1-methylpiperidin-4-yl groups having excellent activities against all four cancer cell lines, and they exhibited scarcely any activities against HL7702. Among them, compound 9b and 9d showed greatly excellent activity against the four kinds of cells, and the IC₅₀ for MCF7 and PC3 cell lines were even less than 3 μM.     

Identification of Influenza PAN Endonuclease Inhibitors via 3D-QSAR Modeling and Docking-Based Virtual Screening

Structural and biochemical studies elucidate that PA_N may contribute to the host protein shutdown observed during influenza A infection. Thus, inhibition of the endonuclease activity of viral RdRP is an attractive approach for novel antiviral therapy. In order to envisage structurally diverse novel compounds with better efficacy as PA_N endonuclease inhibitors, a ligand-based-pharmacophore model was developed using 3D-QSAR pharmacophore generation (HypoGen algorithm) methodology in Discovery Studio. As the training set, 25 compounds were taken to generate a significant pharmacophore model. The selected pharmacophore Hypo1 was further validated by 12 compounds in the test set and was used as a query model for further screening of 1916 compounds containing 71 HIV-1 integrase inhibitors, 37 antibacterial inhibitors, 131 antiviral inhibitors and other 1677 approved drugs by the FDA. Then, six compounds (Hit01–Hit06) with estimated activity values less than 10 μM were subjected to ADMET study and toxicity assessment. Only one potential inhibitory ‘hit’ molecule (Hit01, raltegravir’s derivative) was further scrutinized by molecular docking analysis on the active site of PA_N endonuclease (PDB ID: 6E6W). Hit01 was utilized for designing novel potential PA_N endonuclease inhibitors through lead optimization, and then compounds were screened by pharmacophore Hypo1 and docking studies. Six raltegravir’s derivatives with significant estimated activity values and docking scores were obtained. Further, these results certainly do not confirm or indicate the seven compounds (Hit01, Hit07, Hit08, Hit09, Hit10, Hit11 and Hit12) have antiviral activity, and extensive wet-laboratory experimentation is needed to transmute these compounds into clinical drugs.     

Ginsenoside Rb1 Mitigates Escherichia coli Lipopolysaccharide-Induced Endometritis through TLR4-Mediated NF-κB Pathway

Endometritis is the inflammatory response of the endometrial lining of the uterus and is associated with low conception rates, early embryonic mortality, and prolonged inter-calving intervals, and thus poses huge economic losses to the dairy industry worldwide. Ginsenoside Rb1 (GnRb1) is a natural compound obtained from the roots of Panax ginseng, having several pharmacological and biological properties. However, the anti-inflammatory properties of GnRb1 in lipopolysaccharide (LPS)-challenged endometritis through the TLR4-mediated NF-κB signaling pathway has not yet been researched. This study was planned to evaluate the mechanisms of how GnRb1 rescues LPS-induced endometritis. In the present research, histopathological findings revealed that GnRb1 ameliorated LPS-triggered uterine injury. The ELISA and RT-qPCR assay findings indicated that GnRb1 suppressed the expression level of pro-inflammatory molecules (TNF-α, IL-1β and IL-6) and boosted the level of anti-inflammatory (IL-10) cytokine. Furthermore, the molecular study suggested that GnRb1 attenuated TLR4-mediated NF-κB signaling. The results demonstrated the therapeutic efficacy of GnRb1 in the mouse model of LPS-triggered endometritis via the inhibition of the TLR4-associated NF-κB pathway. Taken together, this study provides a baseline for the protective effect of GnRb1 to treat endometritis in both humans and animals.     

Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the production of β2-glycoprotein I (β2GPI)-dependent autoantibodies, with vascular thrombosis or obstetrical complications. Around 20% of APS patients are refractory to current treatments. Crassolide, a cembranoid diterpene extracted from soft corals, is a potential therapeutic candidate. Here, to examine the anti-inflammatory properties of crassolide, we first determined its effects on bone marrow-derived and splenic dendritic cells (DC). Specifically, we applied lipopolysaccharide (LPS) or β2GPI stimulation and measured the expressions of CD80 and CD86, and secretions of cytokines. We also determined in the OT-II mice, if bone marrow-derived DC was able to stimulate antigen-specific T cells. Moreover, we examined the therapeutic potential of crassolide postimmunization in a murine model of APS that depended on active immunization with β2GPI. The vascular manifestations were evaluated in terms of fluorescein-induced thrombi in mesenteric microvessels, whereas the obstetric manifestations were evaluated based on the proportion of fetal loss after pregnancy. We also measured blood titers of anti-β2GPI antibody, splenic cell proliferative responses and cytokine secretions after β2GPI stimulation ex vivo. Finally, we determined in these mice, hematological, hepatic and renal toxicities of crassolide. Crassolide after LPS stimulation suppressed DC maturation and secretion of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-12 and IL-23, and downstream T cell activation. Crassolide could partially ameliorate both the vascular and obstetric manifestations of APS in BALB/c mice. Both blood titers of anti-β2GPI antibody and splenic cell proliferation after β2GPI stimulation were reduced. Splenic Th1 and Th17 responses were also lowered after β2GPI stimulation. Finally, within therapeutic doses of crassolide, we found no evidence of its toxicity. In conclusion, we showed the ability of crassolide to suppress DC and downstream T cell responses. Crassolide is therefore a potential candidate for adjunctive therapy in APS.     

4,4＇-二苯氧基二苯砜、4,4＇-二苯氧基二苯酮、对苯二甲酰氯三元共聚物的合成

聚醚酮醚酮酮;4;4＇-二苯氧基二苯砜、4;4＇-二苯氧基二苯酮、对苯二甲酰氯三元共聚物的合成;聚醚砜醚酮酮;低温溶液浓缩聚